Pharmacotherapy of cognitive deficits in schizophrenic disorders: a randomised placebo-controlled double-blind study of tolcapone versus pergolide.
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Pergolide; Tolcapone
- Indications Cognition disorders
- Focus Therapeutic Use
- Acronyms TOCTAP
- 02 Oct 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 17 Apr 2010 New trial record